title: Does Antiretroviral Therapy Interfere With the Treatment of Trichomonas vaginalis Among HIV+ Women?
authors.forename: Patricia
authors.initials: P
authors.lastname: Kissinger
authors.forename: Alys
authors.initials: A
authors.lastname: Adamski
authors.forename: Rebecca A
authors.initials: RA
authors.lastname: Clark
authors.forename: Leandro
authors.initials: L
authors.lastname: Mena
authors.forename: Judy
authors.initials: J
authors.lastname: Levison
authors.forename: David H
authors.initials: DH
authors.lastname: Martin
mesh_terms: D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage*; D014247:Trichomonas Vaginitis / Q000188:drug therapy*; D014246:Trichomonas vaginalis / Q000187:drug effects*
chemical_list: D000981:Antiprotozoal Agents; D008795:Metronidazole